Page 108 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
• Preliminary results of QUIWI: a double blinded, randomized clinical trial comparing
standard chemotherapy plus quizartinib versus placebo in adult patients with newly
diagnosed FLT3-ITD wild-type AML.
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (S130).
Montesinos P, Rodríguez-Veiga R, Bergua Burgues JM, Algarra L, Botella C, Pérez Simón
JA, Bernal T, Tormo M, Calbacho Robles M, Salamero O, Serrano J, Noriega V, López-
López JA, Vives Polo S, Colorado M, López Lorenzo JL, Vidriales MB, García Boyero R,
Olave M, Herrera-Puente P, Arce O, Barrios García M, Sayas Lloris MJ, Polo M, Gómez
Roncero MI, Barragán E, Ayala Díaz R, Chillón MC, Calasanz MJ, Boluda B, Martínez-
Cuadrón D, Labrador J.
• Updated results of VEN-A-QUI study: a phase 1-2 trial to assess the safety and ef-
ficacy of triplets for newly diagnosed unfit AML patients: azacitidine or low-dose cy-
tarabine with venetoclax and quizartinib.
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (S132).
Bergua Burgués JM, Rodríguez-Veiga R, Cano Ferri I, Vall-Llovera Calmet F, García-Gui-
ñón A, Gómez Espuch J, Colorado M, Casas-Avilés I, Esteve J, Sampol A, Verdugo MV,
Ramos F, Valero M, Acuña Cruz EG, Boluda B, Torres Miñana L, Martínez-López J, Barra-
gán E, Ayala Díaz R, Martínez Cuadrón D, Montesinos P.
• Analysis of factors associated with long-term survival in a large acute promyelocytic
leukemia (APL) patient cohort: a Harmony Alliance study.
28th Congress of the EHA. EHA2023 Frankfurt & Virtual, Jun (8-11) (S136).
Guarnera L, Lehmann S, Döhner K, Döhner H, Ossenkoppele G, Russell N, Dillon R,
Platzbecker U, Vignetti M, La Sala E, Villaverde Rimero A, Tur L, Hernández Rivas J,
Voso MT.
• First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib Versus Ima-
tinib in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphocytic
Leukemia.
11st Society of Hematologic Oncology (SOHO) Annual Meeting 2023. Hybrid event, 06-09
Sep 2023. (Oral Abstract: ALL-300).
Jabbour E, Kantarjian H, Aldoss I, Montesinos P, Leonard J, Gómez-Almaguer D, Baer M,
Gambacorti-Passerini C, McCloskey J, Minami J, Papayannidis C, Rocha V, Rousselot P,
Vachhani P, Wang E, Hennessy M, Patel N, Vorog A, Wang B, Yeh T, Ribera JM.
108